Cibc Private Wealth Group, LLC Amicus Therapeutics, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,959 shares of FOLD stock, worth $18,923. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,959
Previous 1,959
-0.0%
Holding current value
$18,923
Previous $19,000
5.26%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding FOLD
# of Institutions
313Shares Held
314MCall Options Held
516KPut Options Held
833K-
Vanguard Group Inc Valley Forge, PA28.8MShares$278 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$271 Million7.83% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$235 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA24MShares$231 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY23.2MShares$224 Million3.72% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.71B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...